Effects of cefuroxime on human osteoblastsin vitro

Department of Orthopedic Surgery and Orthopedic Sports Medicine, Technical University of Munich, Germany.
Journal of Biomedical Materials Research Part A (Impact Factor: 2.84). 08/2007; 82(2):462-8. DOI: 10.1002/jbm.a.31158
Source: PubMed

ABSTRACT The local application of antibiotics in bone cement achieves high local effective antibiotic concentrations. Cefuroxime is widely used for antibiotic prophylaxis in orthopedic surgery, and several reports highlighted a beneficial outcome if cefuroxime-impregnated bone cement was used, but there is a lack of information of direct cefuroxime effects on human bone cells. We, therefore, cultured osteoblasts, previously derived from human trabecular bone specimens and used as a cell-pool further on, with different concentrations of cefuroxime (0-1000 microg/mL) for 24, 48, or 72 h. For reversibility testing, osteoblasts were cultivated for 24 h with cefuroxime followed by 48 h without antibiotics. Cell proliferation (MTT), cytotoxicity (lactate dehydrogenase (LDH)-activity), cell metabolism (alkaline phosphatase (ALP)-activity), and extracellular matrix calcification (Alizarin staining) were assessed after antibiotic treatment. Cefuroxime concentrations of 25-100 microg/mL had little or no effect on cellular proliferation. Proliferation was significantly stimulated at 250 and 1000 microg/mL at each time. LDH-activity significantly increased at the highest concentration of 1000 microg/mL at 72 h. ALP-activity first increased at lower concentrations and then significantly decreased at 1000 microg/mL at 48 and 72 h. Similar to ALP-activity, calcification increased at lower concentrations and was not detectable at 1000 microg/mL. All revealed effects at 24 h were at least partially reversible. In the present study, we demonstrated that cefuroxime at lower concentrations had no inhibiting effects on human osteoblasts. In contrast, higher concentrations significantly altered osteoblastic function. When administered locally in total joint arthroplasty, for example, in antibiotic-impregnated bone cement, cefuroxime might critically impair osteoblastic function and periprosthetic bone metabolism.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In this study, encapsulating antibiotic loaded titanium alloy by polylactide-co-polyglycolide copolymer (PLGA) for preventing burst releasing and extending antibiotic releasing time will be make for potential future hip prosthesis with deep infection prevention ability. Antibiotics, vancomycin and cefuroxime, were used to measure their temporal release from titanium disc. The result by elution test showed non PLGA coated of antibiotic loaded groups was released at the first hour. For PLGA (85/15) coated groups, vancomycin could still be detected after 5 days, and cefuroxime groups extended the releasing period to at least 7 days.
    Bioengineering Conference, 2009 IEEE 35th Annual Northeast; 05/2009
  • [Show abstract] [Hide abstract]
    ABSTRACT: Infection and inflammation associated with orthopedic implants can be life threatening, time consuming, and expensive, thus, motivating the development of a local drug delivery platform that could prevent such deleterious events. For this purpose, nanostructured polypyrrole (PPy) incorporating antibiotics and anti-inflammatory drugs (penicillin/streptomycin (P/S) or dexamethasone (Dex), respectively) were coated on commercially pure titanium through an easy to use electrochemical deposition method. As shown in our previous study, about 80% (compared with initial amount) of these incorporated drugs were released after electrical stimulation spanning five cycles (voltage was varied between -1 V and 1 V). In a further continuation of this work, nanostructured P/S incorporated PPy coatings on titanium were demonstrated to be bactericidal against Staphylococcus epidermis after 1 h, and when incorporated with Dex, inhibited macrophage (an inflammatory and immune response cell) growth after 8 and 13 h of in vitro culture. Moreover, nanostructured PPy-drug films coated on titanium enhanced osteoblast (bone forming cells) proliferation, while at the same time, suppressed fibroblast (fibrous tissue forming cells) proliferation for up to 5 days. After electrical stimulation, antimicrobial and anti-inflammatory-coated devices yielded lower bacteria colonies and macrophage growth compared with unincorporated-drug PPy films (controls). This study, thus, suggests that drug incorporated nanostructured PPy coatings on titanium are capable of effectively treating potential orthopedic implant infection and inflammation, and lays the foundation for the further development of local and controllable on-demand drug delivery coatings to improve orthopedic implant efficacy.
    Journal of Biomedical Materials Research Part A 12/2011; 99(4):586-97. DOI:10.1002/jbm.a.33210 · 2.83 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Autogenous cancellous bone graft provides an osteoconductive, osteoinductive, and osteogenic substrate for filling bone voids and augmenting fracture-healing.The iliac crest remains the most frequently used site for bone-graft harvest, but the proximal part of the tibia, distal end of the radius, distal aspect of the tibia, and greater trochanter are alternative donor sites that are particularly useful for bone-grafting in the ipsilateral extremity.The most common complication associated with the harvest of autogenous bone graft is pain at the donor site, with less frequent complications including nerve injury, hematoma, infection, and fracture at the donor site.Induced membranes is a method that uses a temporary polymethylmethacrylate cement spacer to create a bone-graft-friendly environment to facilitate graft incorporation, even in large segmental defects.
    The Journal of Bone and Joint Surgery 12/2011; 93(23):2227-36. DOI:10.2106/JBJS.J.01513 · 4.31 Impact Factor